News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
699,948 Results
Type
Article (39529)
Company Profile (175)
Press Release (660240)
Multimedia
Podcasts (91)
Webinars (12)
Section
Business (220410)
Career Advice (825)
Deals (33452)
Drug Delivery (99)
Drug Development (86338)
Employer Resources (58)
FDA (16462)
Job Trends (13576)
News (335043)
Policy (30954)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Biotech Bay Elite (3)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (2138)
Accelerated approval (55)
ADA (46)
Adcomms (29)
Allergies (203)
Alliances (46615)
ALS (231)
Alzheimer's disease (1866)
Antibody-drug conjugate (ADC) (544)
Approvals (17054)
Artificial intelligence (639)
ASCO (332)
Autoimmune disease (368)
Automation (42)
Bankruptcy (338)
Best Places to Work (10616)
BIO (64)
BIOSECURE Act (8)
Biosimilars (197)
BioSpace Insights (88)
Biotechnology (111)
Bladder cancer (219)
Brain cancer (77)
Breast cancer (829)
Cancer (6475)
Cardiovascular disease (556)
Career advice (715)
Career pathing (21)
CAR-T (348)
CDC (40)
Celiac Disease (3)
Cell therapy (893)
Cervical cancer (59)
Clinical research (77059)
Collaboration (2091)
Commercialization (6)
Company closure (6)
Compensation (1578)
Complete response letters (95)
COVID-19 (2440)
CRISPR (107)
C-suite (1267)
Cystic fibrosis (154)
Data (8855)
Decentralized trials (3)
Denatured (25)
Depression (206)
Dermatology (114)
Diabetes (678)
Diagnostics (6273)
Digital health (59)
Diversity (9)
Diversity, equity & inclusion (20)
Drug discovery (303)
Drug pricing (171)
Drug shortages (25)
Duchenne muscular dystrophy (321)
Earnings (88122)
Editorial (53)
Employer branding (6)
Employer resources (59)
Events (115901)
Executive appointments (1122)
FDA (20702)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (25)
Frontotemporal dementia (35)
Funding (1735)
Gene editing (223)
Generative AI (48)
Gene therapy (680)
GLP-1 (1123)
Government (3981)
Grass and pollen (6)
Guidances (413)
Healthcare (17603)
Hematology (188)
HIV (96)
Huntington's disease (68)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (126)
Immunology and inflammation (337)
Immuno-oncology (115)
Indications (232)
Infectious disease (2801)
Inflammatory bowel disease (235)
Inflation Reduction Act (14)
Influenza (136)
Intellectual property (318)
Interviews (112)
IPO (15618)
IRA (43)
Job creations (3333)
Job search strategy (641)
JPM (40)
Kidney cancer (26)
Labor market (58)
Layoffs (459)
Leadership (15)
Legal (7318)
Licensing (10)
Liver cancer (105)
Longevity (31)
Lung cancer (894)
Lymphoma (500)
Machine learning (48)
Management (19)
Manufacturing (957)
Marketing (12)
MASH (226)
Medical affairs (1)
Medical device (14513)
Medtech (14745)
Mergers & acquisitions (19146)
Metabolic disorders (1699)
mRNA (208)
Multiple sclerosis (206)
NASH (22)
Neurodegenerative disease (500)
Neuropsychiatric disorders (127)
Neuroscience (3600)
Neurotech (1)
NextGen: Class of 2026 (5728)
Non-profit (3441)
Now hiring (49)
Obesity (768)
Opinion (199)
Ovarian cancer (245)
Pain (292)
Pancreatic cancer (368)
Parkinson's disease (408)
Partnered (29)
Patents (628)
Patient recruitment (882)
Peanut (69)
People (57258)
Pharmaceutical (42)
Pharmacy benefit managers (23)
Phase 1 (23974)
Phase 2 (34012)
Phase 3 (25385)
Pipeline (10648)
Policy (228)
Postmarket research (2555)
Preclinical (9052)
Press Release (52)
Prostate cancer (351)
Psychedelics (77)
Radiopharmaceuticals (347)
Rare diseases (1240)
Real estate (5092)
Recruiting (23)
Regulatory (25603)
Reports (31)
Research institute (2111)
Resumes & cover letters (111)
Rett syndrome (47)
RNA editing (24)
RSV (85)
Schizophrenia (197)
Series A (298)
Series B (229)
Service/supplier (6)
Sickle cell disease (115)
Special edition (17)
Spinal muscular atrophy (175)
Sponsored (34)
Startups (3374)
Stomach cancer (18)
Supply chain (112)
Tariffs (54)
The Weekly (66)
Vaccines (1033)
Venture capital (94)
Weight loss (511)
Women's health (136)
Worklife (4)
Date
Today (136)
Last 7 days (703)
Last 30 days (2386)
Last 365 days (29125)
2026 (18224)
2025 (28845)
2024 (33498)
2023 (38020)
2022 (48895)
2021 (52449)
2020 (50224)
2019 (41213)
2018 (31233)
2017 (30006)
2016 (29241)
2015 (35327)
2014 (30052)
2013 (25420)
2012 (27605)
2011 (28129)
2010 (27227)
Location
Africa (564)
Alabama (95)
Alaska (4)
Arizona (375)
Arkansas (16)
Asia (38656)
Australia (6251)
California (14220)
Canada (3896)
China (1516)
Colorado (620)
Connecticut (591)
Delaware (426)
Europe (77359)
Florida (2196)
Georgia (460)
Hawaii (3)
Idaho (57)
Illinois (1153)
India (87)
Indiana (585)
Iowa (19)
Japan (602)
Kansas (132)
Kentucky (48)
Louisiana (57)
Maine (35)
Maryland (1680)
Massachusetts (9953)
Michigan (384)
Minnesota (787)
Mississippi (7)
Missouri (136)
Montana (35)
Nebraska (26)
Nevada (156)
New Hampshire (85)
New Jersey (3709)
New Mexico (22)
New York (3733)
North Carolina (1857)
North Dakota (8)
Northern California (7208)
Ohio (394)
Oklahoma (20)
Oregon (42)
Pennsylvania (2763)
Puerto Rico (30)
Rhode Island (50)
South America (831)
South Carolina (88)
South Dakota (1)
Southern California (5714)
Tennessee (229)
Texas (2322)
United States (49778)
Utah (433)
Vermont (1)
Virginia (331)
Washington D.C. (68)
Washington State (1129)
West Virginia (4)
Wisconsin (128)
Wyoming (1)
699,948 Results for "phase iii medical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Summit Therapeutics Signs Agreement to Sell Phase III Asset Ridinilazole to Biossil, Inc.
July 14, 2026
·
9 min read
Press Releases
Ipsen provides update on Phase III BOLD trial in biliary atresia
July 24, 2026
·
9 min read
Press Releases
RenovoRx Achieves Major Milestone with Full Enrollment in Phase III TIGeR-PaC Trial for Locally Advanced Pancreatic Cancer
August 11, 2026
·
12 min read
Rare disease
Sanofi Rare Disease Drug Scores a Hit and a Miss in Phase III Tests
Sanofi will take venglustat to regulators for Gaucher disease but an application for Fabry disease is less clear after the failure of a Phase III trial.
February 2, 2026
·
1 min read
·
Annalee Armstrong
Press Releases
InnoCare’s TYK2 Inhibitor Fadeucravacitinib (ICP-488) Meets Primary Endpoint in Phase III Psoriasis Study
July 27, 2026
·
3 min read
Press Releases
Summit Therapeutics Further Expands Ivonescimab Global Development Program with Phase II/III HARMONi-GU1 Study in 1L Bladder Cancer
August 5, 2026
·
14 min read
Press Releases
GIP Moves from Supporting Role to Key Variable: BrightGene Bio-Medical’s Phase III Results Signal Differentiation in Weight Loss Arena
May 12, 2026
·
8 min read
Press Releases
Lynk Pharmaceuticals Announces Completion of Patient Enrollment in Phase III Clinical Trial of Zemprocitinib for Ankylosing Spondylitis
July 15, 2026
·
5 min read
Press Releases
Insilico Initiates Phase III Clinical Trial for Rentosertib, Its AI-Empowered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis
July 7, 2026
·
15 min read
Cardiovascular disease
Bayer Sets Up Redemption Arc for Anticoagulant With ‘Surprisingly Positive’ Phase III Data
Asundexian’s Phase III win could also bode well for Bristol Myers Squibb, which is also developing a Factor XIa inhibitor called milvexian for stroke prevention, analysts said.
November 24, 2025
·
2 min read
·
Tristan Manalac
1 of 69,995
Next
